TRACT is an international, inter-sectoral, multi-disciplinary project providing Marie Skłodowska-Curie PhD Fellowships to early stage researchers (ESRs) with the potential to become the leaders of tomorrow in cancer research. This project has received funding from the European Union’s Horizon 2020 research & innovation programme under the Marie Skłodowska-Curie grant agreement No. 721906.
PhD Fellows will complete research projects in critical thematic areas; biomarker discovery, molecular resistance mechanisms and metabolic transformation mechanisms that will lead to new insights into the molecular and cellular basis of oral and oesophageal cancer. Fellows will be exposed to next-generation technologies in cancer diagnosis, metabolism, CRISPR and next-gen sequencing, imaging, biomarker, exosome analysis, medicinal chemistry, bioinformatics and drug discovery.
Visit https://www.tcd.ie/Biochemistry/postgraduate/for details of projects being offered and further details.
Research Fields
Medical sciences - Medicine
Chemistry - Biochemistry
Eligibility criteria
Applicants should hold the necessary qualifications entitling them to undertake PhD study in their chosen country, and should possess a high standard of written and spoken English. Prospective PhD candidates should hold at least a 2:1 BSc or alternatively an MSc degree, or equivalent, in biochemistry, molecular biology, immunology, medicinal chemistry, synthetic organic chemistry or related disciplines. Graduates in dental science with a special interest in oral medicine are also encouraged to apply. Relevant research experience is desirable. Applicants must be in the first 4 years of their career post primary degree and not yet hold a doctoral degree. TRACT is a mobility-based EU project and researchers are required to move country to commence their PhD training project. Applicants must not have been resident in the country where the ESR project is being hosted for more than 12 months in the past 3 years.
Further details:
http://ec.europa.eu